Updated:
SomnoMed
SomnoMed has shipped over one million oral sleep apnea devices since 2004, competing against CPAP from Frisco, Texas across 28 countries.
SomnoMed
SomnoMed began in 2004 with a thesis that a custom-fabricated oral appliance could disrupt the CPAP-dominated sleep apnea market. The company now operates in 28 countries from its Frisco, Texas headquarters, manufacturing every SomnoDent device to medical-grade tolerances—the firm says it applies the same quality standards used for pacemakers to its mandibular advancement splints. Distribution runs through a network of sleep physicians and dentists who take patient impressions or digital scans; SomnoMed then fabricates the appliance and returns it for fitting, billing the model as First Time Fit. The product line targets the full severity spectrum of obstructive sleep apnea, anchored by the SomnoDent Avant and the Medicare-approved SomnoDent Herbst Advance Elite. Patients report 6.9 hours of average nightly use, with 91% claiming improved sleep quality after switching from CPAP. The firm does not disclose allocation by asset class—it is an operating medical-device company, not an investment vehicle—making direct comparison to family-office portfolio construction irrelevant. Geographic reach spans the US, Europe, and Asia-Pacific, with the firm describing itself as the world's largest supplier in the category. SomnoMed announces no total deployment figures, AUM, or team headcount. The Altss research record shows no captured LinkedIn page and no named principals. The website frames the company through patient testimonials and clinical outcomes rather than executive biography. The most recent verifiable operational event is the one-millionth device shipment, reported on the firm's own site at an unspecified date within the current product cycle. The structural differentiator is a direct-to-clinician manufacturing model that bypasses the hospital-based durable-medical-equipment channel traditional CPAP suppliers rely on. By capturing the patient at the dentist's office rather than the sleep lab, SomnoMed inserts itself earlier in the treatment pathway and collects margin on custom fabrication rather than commodity mask resale.
General information
Firm type
other
Year founded
2004
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Frisco
Corporate office
Frisco, TX, United States
Sector focus
Frequently asked questions
Is SomnoMed a family office, venture firm, or operating company?
SomnoMed operates as a medical-device manufacturer and distributor. It is not structured as a family office or investment firm. The firm designs, fabricates, and sells oral appliances for obstructive sleep apnea—principally the SomnoDent line—through a clinician network spanning 28 countries. No investment portfolio or family-office structure is disclosed on its website or in the Altss research record.
How does SomnoMed source its business, and who are its customers?
SomnoMed sells through sleep physicians and dentists rather than direct-to-consumer. A patient receives a diagnosis, the clinician takes impressions or a digital scan, SomnoMed manufactures the custom appliance, and the clinician fits the device. The model makes the prescribing doctor the distribution channel, which creates a recurring referral dynamic between sleep labs and dental practices.
Where does SomnoMed manufacture its devices, and what is its geographic footprint?
The firm does not disclose factory locations on its site. It does claim operations in 28 countries and references the US, European, and Asia-Pacific markets. Its corporate headquarters is in Frisco, Texas. All devices are custom-fabricated per patient, and the firm states it applies medical-device quality standards comparable to those used for pacemakers.
What makes SomnoMed structurally different from a CPAP manufacturer?
SomnoMed does not compete in the CPAP hardware or mask market. It focuses exclusively on mandibular advancement devices that reposition the jaw to maintain an open airway. The business model shifts fulfillment from the durable-medical-equipment supply chain—where CPAP masks and machines dominate—to the dental channel, where the appliance is prescribed, fabricated, and fitted in a single workflow.
Does SomnoMed have any known relationships with family offices, institutional allocators, or external investment managers?
No such relationships appear in the available sources. The firm's website and the Altss research record contain no references to investment partnerships, co-investment vehicles, or family-office backing. As an operating company, SomnoMed's capital structure, shareholder base, and any institutional funding rounds are not detailed in the materials reviewed for this profile.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: